James Stephen Mccready Mortensen
Director of Finance/CFO chez CHEMRING GROUP PLC
Fortune : 135 385 $ au 31/03/2024
Profil
James Stephen Mccready Mortensen is currently the Chief Financial Officer & Director at Chemring Group Plc since 2024.
He is also a Director at ICU Medical Group Ltd.
Additionally, he completed his undergraduate degree at the University of Bristol.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
CHEMRING GROUP PLC
0,01% | 13/12/2023 | 29 524 ( 0,01% ) | 135 385 $ | 31/03/2024 |
Postes actifs de James Stephen Mccready Mortensen
Sociétés | Poste | Début |
---|---|---|
CHEMRING GROUP PLC | Director of Finance/CFO | 01/01/2024 |
ICU Medical Group Ltd.
ICU Medical Group Ltd. Medical SpecialtiesHealth Technology Part of ICU Medical, Inc., ICU Medical Group Ltd. is a British company that manufactures specialty medical devices. The private company is based in Ashford, UK. JehanZeb Noor has been the CEO of the company since 2019. ICU Medical Group was acquired by ICU Medical, Inc. from Smiths Group Plc on January 06, 2022 for $3,460.41 million. | Director/Board Member | - |
Formation de James Stephen Mccready Mortensen
University of Bristol | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CHEMRING GROUP PLC | Electronic Technology |
Entreprise privées | 1 |
---|---|
ICU Medical Group Ltd.
ICU Medical Group Ltd. Medical SpecialtiesHealth Technology Part of ICU Medical, Inc., ICU Medical Group Ltd. is a British company that manufactures specialty medical devices. The private company is based in Ashford, UK. JehanZeb Noor has been the CEO of the company since 2019. ICU Medical Group was acquired by ICU Medical, Inc. from Smiths Group Plc on January 06, 2022 for $3,460.41 million. | Health Technology |